About this trial
The prevalence of chronic rheumatic heart disease (RHD) on the island of Mayotte is unknown, but it appears to be high and is responsible for significant morbidity and mortality. Screening for RHD in schools is currently the only strategy for managing the cardiac complications of the disease; however, it requires trained medical personnel-a resource that is lacking in Mayotte, as is the case in many developing countries where the disease is endemic. RHD is a sequela of \*Streptococcus pyogenes\* infection, which can originate from tonsillitis or from impetigo secondary to a scabies infestation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
In one of 30 fourth-grade classes, selected at random from all fourth-grade classes in the department of Mayotte.
For whom at least one of the two holders of parental authority has provided consent (no later than the day of inclusion and prior to any examination required by the research).
Present on the day of the screening and consenting to two ultrasound examinations, each lasting 5 to 20 minutes.
Disqualifiers
Students under guardianship.
Trial design
Single group
Treatments tested in this trial
Ultrasound performed bycardiologis for diagnosis of rheumatic heart disease
DeviceThe following views will be obtained. These include the standard views used for routine screening, plus additional views to screen for common pediatric conditions: parasternal long-axis, parasternal short-axis (aortic level), parasternal short-axis (mitral level), three-chamber, two-chamber, subcostal four-chamber (to screen for an atrial septal defect), parasternal short-axis (at the base), and suprasternal (to screen for a patent ductus arteriosus).
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of rheumatic heart disease (RHD) among children in the fourth year of primary school (CM1) in the population of Mayotte, based on the screening criteria proposed by the WHF in 2023.
Prevalence of rheumatic heart disease (RHD) among children in the fourth year of primary school (CM1) in the population of Mayotte, based on the screening criteria proposed by the WHF in 2023.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: